Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Schrimpf

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|April 13, 2017
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic driversAndrey Korshunov, Daniel Schrimpf, Marina Ryzhova, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Clinical Sarcoma Research|February 28, 2019
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotypeChristian Koelsche, Damian Stichel, Klaus G Griewank, et al.
Acta Neuropathologica|May 13, 2015
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHODavid E Reuss, Yasin Mamatjan, Daniel Schrimpf, et al.
Genes, Chromosomes & Cancer|February 5, 2016
Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomasFelix Sahm, Frederick A Jakobiec, Jochen Meyer, et al.
Communications Medicine|December 19, 2023
Concurrent gliomas in patients with multiple sclerosisKatharina Sahm, Tobias Kessler, Philipp Eisele, et al.
Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.
Acta Neuropathologica|November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaDavid E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort StudyAlberto Delaidelli, Christopher Dunham, Mariarita Santi, et al.
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|April 13, 2017
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic driversAndrey Korshunov, Daniel Schrimpf, Marina Ryzhova, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Clinical Sarcoma Research|February 28, 2019
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotypeChristian Koelsche, Damian Stichel, Klaus G Griewank, et al.
Acta Neuropathologica|May 13, 2015
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHODavid E Reuss, Yasin Mamatjan, Daniel Schrimpf, et al.
Genes, Chromosomes & Cancer|February 5, 2016
Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomasFelix Sahm, Frederick A Jakobiec, Jochen Meyer, et al.
Communications Medicine|December 19, 2023
Concurrent gliomas in patients with multiple sclerosisKatharina Sahm, Tobias Kessler, Philipp Eisele, et al.
Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.
Acta Neuropathologica|November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaDavid E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort StudyAlberto Delaidelli, Christopher Dunham, Mariarita Santi, et al.
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Pageof 13